DOCS Stock Price Today (July 2026) — Doximity, Inc. Analysis & Key Metrics 2026-07-17
Doximity, Inc. (DOCS) is trading at $21.52, down 3.11% today (as of July 2026). The stock continues to show early recovery signs above the short-term average, attracting attention from investors looking for Healthcare growth opportunities.
- According to consensus analyst estimates, the 1-year price target is $24.37 (13.2% upside).
- Volatility remains elevated (34.66% annualized), implying wide price swings for short-term traders.
- The fundamental picture, based on the latest financial filings, is nuanced: solid revenue growth (5.10% YoY) alongside significant competitive pressures.
DOCS Stock Analysis: Key Metrics & Valuation (July 2026)
Concise, actionable data for investors
Doximity, Inc. - Historical Price & Volume
Market Cap
Enterprise Value: $3.05B
P/E Ratio
Forward P/E: 13.01
Revenue Growth
Year over Year
Analyst Target
+13.2% upside potential
Key Investor Questions About DOCS
What investors need to know before buying
Based on current market data, DOCS presents a neutral technical setup with looking solid fundamentals.
- Technicals say: Neutral (RSI 49.06)
- Fundamentals say: Looking solid (debt and growth supportive)
DOCS's growth trajectory depends on its ability to expand within the Health Information Services sector while managing margin pressures.
- Future growth will depend on performance in core Health Information Services operations.
- The ability to manage competitive pressures will be crucial for sustained growth.
The primary risks for DOCS investors include debt exposure and competitive dynamics in the Health Information Services industry.
- $10.19M in debt could be a headwind in a high-rate environment.
- Fierce competition from established players in Health Information Services.
52-Week Trading Range
Over the past year, DOCS stock traded between $17.15 and $76.51—recovering meaningfully from lows and currently near the higher end. Big swings are likely unless a major catalyst emerges.
Volatility & Risk Profile
With 34.66% annualized volatility and β=0.99, the stock exhibits moderate correlation to market moves—making DOCS suitable for investors comfortable with active risk management.
Institutional & Insider Ownership
High institutional backing, but elevated short interest signals a potential battleground stock.
Analyst Sentiment & Price Targets
Latest News & Headlines
Recent headlines and coverage
Zoom, AppLovin, and Doximity Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after sentiment continued to weaken as tech stocks faced a dual headwind of deteriorating macro conditions and an unwinding of retail leverage.
Doximity (DOCS) Declines More Than Market: Some Information for Investors
Doximity (DOCS) closed at $21.52 in the latest trading session, marking a -3.11% move from the prior day.
Reasons to Retain Doximity Stock in Your Portfolio for Now
DOCS is ramping up AI across physician workflows and enterprise tools, but weak pharma ads and higher AI spending may test near-term growth.
Doximity (DOCS) Stock Declines While Market Improves: Some Information for Investors
In the closing of the recent trading day, Doximity (DOCS) stood at $21.77, denoting a -1.09% move from the preceding trading day.
Winners And Losers Of Q1: Doximity (NYSE:DOCS) Vs The Rest Of The Vertical Software Stocks
Looking back on vertical software stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Doximity (NYSE:DOCS) and its peers.
Tenable, Asana, and Doximity Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after President Trump declared the Iran ceasefire "over" and threatened renewed strikes, sending oil higher and bond yields up in a session that punished high-multiple tech.
Doximity’s Shift Into Value Indices Might Change The Case For Investing In DOCS
On 27 June 2026, Doximity, Inc. (NYSE:DOCS) was reclassified across Russell indices, leaving multiple growth benchmarks and joining several value and value-defensive benchmarks, including the Russell 1000 Value and Russell Midcap Value. This broad shift from growth to value indices signals that index providers now classify Doximity’s profile as more value-oriented and defensive than before. We’ll now examine how this move into value and value‑defensive benchmarks could reshape Doximity’s...
Doximity (DOCS) Stock Looks Cheap On Cash Flow But Fair On Earnings
Doximity’s share price has fallen sharply over the past year, yet the stock screens as cheap on several valuation checks and a Discounted Cash Flow (DCF) intrinsic value estimate points to meaningful upside relative to the current market price. Over the past 1 year, Doximity’s share price has declined 64.6%, which puts recent trading firmly in reset territory rather than reflecting any near term rally. On the positive side, investors are focused on Doximity’s physician network and digital...
Doximity (DOCS) Stock Moves 1.25%: What You Should Know
In the most recent trading session, Doximity (DOCS) closed at $21.86, indicating a +1.25% shift from the previous trading day.
Q2 Holdings, RingCentral, and Doximity Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after Guggenheim's John DiFucci upgraded both Salesforce and ServiceNow to Buy, arguing the AI-disruption fear that gutted the sector during the year had pushed valuations too low.
Frequently Asked Questions
Common investor questions about Doximity, Inc.
Doximity, Inc. (DOCS) is currently trading at $21.52. The RSI (14-day) is at 49.1, indicating neutral territory. Wall Street analysts have a consensus "buy" recommendation. The mean analyst price target of $24.37 implies 13.2% upside from current levels. Volatility is moderate at 34.7% annualized, meaning price movements are relatively contained. Investors should consider their risk tolerance, investment horizon, and portfolio diversification before making a decision.
Based on current valuation metrics for Doximity, Inc. (DOCS): The trailing P/E ratio is 21.96, which is in line with broader market averages. The forward P/E is 13.01, lower than the trailing P/E, suggesting analysts expect earnings improvement. The PEG ratio is 0.59, below 1.0, which generally indicates the stock is undervalued relative to its growth rate. Price-to-Book is 4.14. Price-to-Sales is 4.40. Valuation should be compared to Health Information Services industry peers for context, as different sectors trade at different multiples.
Based on 19 analysts covering DOCS, the consensus price target is $24.37. This represents a 13.2% upside from the current price of $21.52. The range spans from a low target of $18.00 to a high target of $42.00, reflecting varying levels of optimism among analysts. The consensus recommendation is "buy". Note: Analyst price targets are forward-looking estimates and not guarantees of future performance.
Doximity, Inc. (DOCS) does not currently pay a regular dividend. The company may be reinvesting profits into growth initiatives, or may not yet be profitable enough to distribute earnings to shareholders.
Key risks for Doximity, Inc. (DOCS) investors include: 1. Moderate volatility (34.7% annualized)—price swings are notable. 2. Elevated short interest (14.6% of float) suggests significant bearish sentiment. 3. Broader market and macroeconomic risks (interest rates, inflation, geopolitical events). 4. Health Information Services sector-specific competitive pressures. Investors should diversify and consider their risk tolerance before investing.
Here is Doximity, Inc.'s (DOCS) current debt and financial health profile: Total debt stands at $10.19M. The debt-to-equity ratio is 1.07, which is conservative and indicates a strong balance sheet with low leverage. The current ratio is 6.09, indicating strong short-term liquidity. The quick ratio is 5.81. The company holds $748.60M in cash and equivalents. Free cash flow is positive at $255.26M, providing a cushion for debt servicing and shareholder returns.